Shenzhen Historical Cash Flow
| 300760 Stock | 254.50 5.87 2.25% |
Analysis of Shenzhen Mindray cash flow over time is an excellent tool to project Shenzhen Mindray Bio future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 12.9 B or Capital Expenditures of 3.2 B as it is a great indicator of Shenzhen Mindray ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Shenzhen Mindray Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shenzhen Mindray Bio is a good buy for the upcoming year.
Shenzhen |
About Shenzhen Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Shenzhen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shenzhen's non-liquid assets can be easily converted into cash.
Shenzhen Mindray Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Shenzhen Mindray Bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Shenzhen Mindray operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Shenzhen Mindray's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Shenzhen Mindray Bio current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Mindray Bio Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Shenzhen Mindray's Depreciation is projected to increase significantly based on the last few years of reporting. The current year's Dividends Paid is expected to grow to about 12.9 B, whereas Change To Inventory is forecasted to decline to (243.2 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Dividends Paid | 4.2B | 10.7B | 12.3B | 12.9B | Depreciation | 885.1M | 1.0B | 1.2B | 1.2B |
Shenzhen Mindray cash flow statement Correlations
Click cells to compare fundamentals
Shenzhen Mindray Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Shenzhen Mindray cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (1.4B) | (133.6M) | (523.0M) | (201.4M) | (231.6M) | (243.2M) | |
| Change In Cash | 1.6B | (589.8M) | 3.8B | (305.2M) | (274.7M) | (261.0M) | |
| Total Cashflows From Investing Activities | (778.0M) | (5.2B) | (4.8B) | (3.2B) | (2.9B) | (2.8B) | |
| Other Cashflows From Financing Activities | (25.9M) | (29.6M) | (27.7M) | (961.4M) | (865.3M) | (822.0M) | |
| Depreciation | 472.1M | 666.2M | 885.1M | 1.0B | 1.2B | 1.2B | |
| Dividends Paid | 1.8B | 3.0B | 4.2B | 10.7B | 12.3B | 12.9B | |
| Capital Expenditures | 1.2B | 1.4B | 1.9B | 2.7B | 3.1B | 3.2B | |
| Total Cash From Operating Activities | 8.9B | 9.0B | 12.1B | 11.1B | 12.7B | 7.1B | |
| Change To Account Receivables | (312.3M) | (3.3M) | (153.4M) | (1.0B) | (942.3M) | (895.2M) | |
| Net Income | 6.7B | 8.0B | 9.6B | 11.6B | 13.3B | 14.0B | |
| Total Cash From Financing Activities | (1.2B) | (1.9B) | (4.6B) | (5.2B) | (4.7B) | (4.4B) | |
| Change To Netincome | 164.3M | 407.3M | (107.9M) | (112.4M) | (101.2M) | (96.1M) | |
| Change To Liabilities | 504.4M | 2.8B | 675.0M | 2.9B | 3.4B | 3.5B | |
| End Period Cash Flow | 15.7B | 15.1B | 19.0B | 18.7B | 21.5B | 14.2B | |
| Free Cash Flow | 7.7B | 7.6B | 10.2B | 8.4B | 9.6B | 6.9B | |
| Change In Working Capital | 1.4B | 387.9M | 1.3B | (2.3B) | (2.1B) | (2.0B) | |
| Begin Period Cash Flow | 14.1B | 15.7B | 15.1B | 19.0B | 21.8B | 13.3B | |
| Other Non Cash Items | 215.6M | (210.3M) | (214.3M) | (188.0M) | (169.2M) | (160.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shenzhen Stock
The Cash Flow Statement is a financial statement that shows how changes in Shenzhen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shenzhen's non-liquid assets can be easily converted into cash.